|
⚲
|
| Keyboard |
| Bain Capital Life Sciences Investors LLC
✚
|
|
|---|---|
| CIK # | 0001703031 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Heartflow Inc | 254.2 | ||
| Newamsterdam Pharma Co NV | 233.9 | ||
| Olema Pharmaceuticals Inc | 111.4 | ||
| Adventrx Pharmaceuticals Inc | 96.1 | ||
| Pharvaris NV | 75.6 | ||
| Solid Biosciences Inc | 70.6 | ||
| Arsanis Inc | 32.9 | ||
| Magenta Therapeutics Inc | 30.4 | ||
| Annexon Inc | 28.9 | ||
| Kyverna Therapeutics Inc | 26.8 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001703031] | |
| 3 | [0001703031] | |
| 4 | [0001703031] | |
| SC 13G | [0001703031] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Bain Capital Life Sciences Investors LLC | Third Harmonic Bio Inc | [2022-09-29] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Heartflow Inc HTFL
Common Stock
|
2026-02-04 | Sell | 2,000,000 | $28.05 | 56,100,000 |
|
Heartflow Inc HTFL
Common Stock
|
2025-08-11 | Conversion | 433,924 | $15.20 | 6,595,645 |
|
Heartflow Inc HTFL
Subordinated Convertible Promissory Note · derivative
|
2025-08-11 | Conversion | $0.00 | ||
|
Heartflow Inc HTFL
Series F Preferred Stock · derivative
|
2025-08-11 | Conversion | 35,081,564 | $0.00 | |
|
Heartflow Inc HTFL
Common Stock
|
2025-08-11 | Conversion | 12,014,234 | ||
|
Solid Biosciences Inc SLDB
Pre-Funded Warrant (right to buy) · derivative
|
2025-02-19 | Buy | 6,444,170 | $4.03 | 25,970,005 |
|
Solid Biosciences Inc SLDB
Common Stock
|
2025-02-19 | Buy | 1,000,000 | $4.03 | 4,030,000 |
|
Olema Pharmaceuticals Inc OLMA
Pre-Funded Warrant (right to buy) · derivative
|
2025-01-10 | Other | 3,500,000 | ||
|
Olema Pharmaceuticals Inc OLMA
Common Stock
|
2025-01-10 | Other | 3,500,000 | ||
|
Olema Pharmaceuticals Inc OLMA
Common Stock
|
2025-01-08 | Buy | 300,000 | $5.76 | 1,728,000 |
|
NewAmsterdam Pharma Co NV NAMS
Pre-Funded Warrant (right to buy) · derivative
|
2024-12-13 | Buy | 1,632,653 | $24.50 | 39,999,998 |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 2,713,868 | ||
|
Kyverna Therapeutics Inc KYTX
Series B Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 12,351,087 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 450,000 | $22.00 | 9,900,000 |
|
Solid Biosciences Inc SLDB
Common Stock
|
2024-01-11 | Grant | 904,160 | $5.53 | 5,000,005 |
|
Annexon Inc ANNX
Common Stock
|
2023-05-25 | Buy | 300,000 | $2.13 | 639,000 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-10 | Buy | 21,812 | $9.56 | 208,523 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-10 | Buy | 3,188 | $10.24 | 32,645 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-09 | Buy | 4,011 | $9.84 | 39,468 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-08 | Buy | 13,458 | $9.62 | 129,466 |
| showing 20 of 57 most recent transactions | |||||